Crispr Therapeutics shares owned by Evermay Wealth Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Evermay Wealth Management
from 13F filings
Historical chart of Evermay Wealth Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Evermay Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Evermay Wealth Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $113k | 1.8k | 62.60 |
| 2023-09-30 | $5.9k | 130 | 45.39 |
| 2023-06-30 | $7.3k | 130 | 56.15 |
| 2023-03-31 | $5.9k | 130 | 45.23 |
| 2022-12-31 | $5.3k | 130 | 40.65 |
| 2022-09-30 | $8.0k | 130 | 61.54 |
| 2022-06-30 | $6.0k | 100 | 60.00 |